Suspected quality defect: out-of-specification (OOS) results for the parameters Lorazepam content and Lorazepam related substances, which may indicate an incorrect amount of active substance and impurities in the solution for injection. Potential effects: lack of treatment efficacy, excessive sedative effect, adverse reactions, complications.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use the product from batch A905BB; patients who have this medicine should consult a doctor or pharmacist regarding further treatment and possible return of the packs to a pharmacy.
The distribution of batch A905BB of Lorabex 4 mg/ml, solution for injection, has been suspended throughout the country, with the decision given immediate enforceability; the marketing authorisation ho...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related